Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 22.2% decrease from the number of companies inspected in the previous quarter, when nine companies received nine inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics and Biologics sectors. The second most common type of company inspected worked in the Drugs sector.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Eric J. Lawitz, M.D. | Drugs | 01/19/2024 | No Action Indicated (NAI) |
| Flowers Baking Company of San Antonio, LLC | Food and Cosmetics | 01/23/2024 | No Action Indicated (NAI) |
| Fresh From Texas, Inc. | Food and Cosmetics | 01/22/2024 | No Action Indicated (NAI) |
| Mega PG Distributions | Food and Cosmetics | 02/26/2024 | No Action Indicated (NAI) |
| RegenTX Partners, LLC | Biologics | 01/23/2024 | No Action Indicated (NAI) |
| Stability Biologics, LLC | Biologics | 03/07/2024 | No Action Indicated (NAI) |
| University Health | Biologics | 01/16/2024 | No Action Indicated (NAI) |
Alerts Sign-up